As a response to the COVID-19 pandemic, introducing immunity passports as a governmental initiative have been discussed and explored. In a first-time conversation between Harvard Medical School bioethicist Natalie Kofler and Albert Wenger, managing partner at Union Square Ventures, we’ll dive into the idea of “immunocapital” and its implications for the further fragmentation of society.